(+)-PENTAZOCINE - DEA SCHEDULE IV ITEM

CAS No.
7361-76-4
Chemical Name:
(+)-PENTAZOCINE - DEA SCHEDULE IV ITEM
Synonyms
Pentazozine;(2S,6S,11S)-;d-Pentazocine;(+)-cis-Pentazocine;(+)-PENTAZOCINE - DEA SCHEDULE IV ITEM;(11S)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2β,6β-methano-3-benzazocin-8-ol;(11S)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2β,6β-methano-3-benzazocine-8-ol;(2S,11S)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2β,6β-methano-3-benzazocin-8-ol;[2S,6S,11S,(+)]-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocine-8-ol;2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-, (2S,6S,11S)- (9CI)
CBNumber:
CB1504116
Molecular Formula:
C19H27NO
Molecular Weight:
285.43
MDL Number:
MOL File:
7361-76-4.mol
Last updated:2023-04-23 13:52:06

(+)-PENTAZOCINE - DEA SCHEDULE IV ITEM Properties

Boiling point 403.5±45.0 °C(Predicted)
Density 1.036±0.06 g/cm3(Predicted)
pka 10.10±0.60(Predicted)
form solid
color white
optical activity [α]23/D +134.6°, c = 1 in chloroform(lit.)
FDA UNII A2G9VU2P2J

SAFETY

Risk and Safety Statements

Symbol(GHS)  GHS hazard pictograms
GHS07
Signal word  Warning
Hazard statements  H302+H312+H332
Precautionary statements  P261-P264-P280-P301+P312-P302+P352+P312-P304+P340+P312
Hazard Codes  Xn
Risk Statements  20/21/22
Safety Statements  36
WGK Germany  3

(+)-PENTAZOCINE - DEA SCHEDULE IV ITEM Chemical Properties,Uses,Production

Uses

Mixed opioid agonist-antagonist. Controlled substance. Analgesic (narcotic).

(+)-PENTAZOCINE - DEA SCHEDULE IV ITEM Preparation Products And Raw materials

Raw materials

Preparation Products

(+)-PENTAZOCINE - DEA SCHEDULE IV ITEM (11S)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2β,6β-methano-3-benzazocin-8-ol (11S)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2β,6β-methano-3-benzazocine-8-ol (2S,11S)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2β,6β-methano-3-benzazocin-8-ol [2S,6S,11S,(+)]-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocine-8-ol d-Pentazocine (2S,6S,11S)- Pentazozine 2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-, (2S,6S,11S)- (9CI) (+)-cis-Pentazocine 7361-76-4 Agonists Opioids Pharmacologicals Chiral Reagents Heterocycles Intermediates & Fine Chemicals Pharmaceuticals